Oncolytics Biotech (ONCY) Cash & Equivalents (2009 - 2026)
Oncolytics Biotech (ONCY) posted Cash & Equivalents of $4.12 million for Q2 2026, down 61.0% from $10.56 million a year earlier.
Powered by 
Analysis
Oncolytics Biotech (ONCY) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2025, Oncolytics Biotech's Cash & Equivalents came in at $5.2 million, down 53.0% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -25.9% (FY2020 to FY2025).
- In prior years, Oncolytics Biotech's Cash & Equivalents was $11.08 million in FY2024 (-57.2%), $25.88 million in FY2023 (+188.4%), $8.97 million in FY2022 (-72.7%) and $32.93 million in FY2021 (+41.3%).
- The Q2 2026 figure stands as the lowest quarterly Cash & Equivalents in data going back to Q1 2009.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q4 2023, with growth of 198.4%; the weakest was Q4 2022, with a decline of 73.7%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Oncolytics Biotech | 62.32 Mn | 33.44 Mn | - | 4.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.12 Mn |
| Dec 31, 2025 | 5.20 Mn |
| Sep 30, 2025 | 8.88 Mn |
| Jun 30, 2025 | 10.69 Mn |
| Mar 31, 2025 | 10.69 Mn |
| Dec 31, 2024 | 11.11 Mn |
| Sep 30, 2024 | 14.51 Mn |
| Jun 30, 2024 | 18.14 Mn |
| Mar 31, 2024 | 21.87 Mn |
| Dec 31, 2023 | 26.39 Mn |
| Sep 30, 2023 | 29.64 Mn |
| Jun 30, 2023 | 13.22 Mn |
| Mar 31, 2023 | 11.74 Mn |
| Dec 31, 2022 | 8.61 Mn |
| Sep 30, 2022 | 23.67 Mn |
| Jun 30, 2022 | 26.15 Mn |
| Mar 31, 2022 | 31.63 Mn |
| Dec 31, 2021 | 32.38 Mn |
| Sep 30, 2021 | 37.70 Mn |
| Jun 30, 2021 | 40.98 Mn |
API Access
Oncolytics Biotech Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ONCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ONCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ONCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();